title: Novobiocin inhibits both UDP-glucuronosyltransferase and cytochrome P450-mediated enzyme activities in pig liver microsomes.
abstract: The effects of novobiocin (range 0.0125-2 mmol/L) on the hydroxylation of testosterone, the N-demethylation of erythromycin, and the glucuronidation of alpha-naphthol and paracetamol were studied using pig hepatic microsomes, pooled from five animals. The final concentrations of these substrates in the incubation mixtures were selected to meet Vmax conditions. Novobiocin caused a concentration-dependent inhibition of the glucuronidation of paracetamol; the formation of alpha-naphthol-glucuronide was reduced to a lesser degree. These results confirm and extend earlier findings in laboratory animal species that novobiocin inhibits UDP-glucuronosyltransferases (UDPGTs). Moreover, novobiocin strongly inhibited 6 beta-hydroxylation of testosterone. The microsomal N-demethylation of erythromycin and hydroxylation of testosterone at the 15 alpha position were less affected by novobiocin. These results suggest that novobiocin inhibits not only UDPGTs, but also cytochrome P450 (CYP) enzyme activities, probably those belonging to the CYP3A subfamily. More research is needed to reveal which CYPs and UDPGTs are affected by novobiocin in vivo, in order to improve the understanding the probably the predictability of potential drug interactions with this antibiotic.
authors.affiliation: MaCaulay Land Use Research Institute, Aberdeen, UK.
authors.forename: D
authors.initials: D
authors.lastname: Villar
authors.forename: N
authors.initials: N
authors.lastname: Furusawa
authors.forename: M
authors.initials: M
authors.lastname: Monshouwer
authors.forename: A S
authors.initials: AS
authors.lastname: Van Miert
mesh_terms: D000082:Acetaminophen / Q000494:pharmacology; D000818:Animals; D002851:Chromatography, High Pressure Liquid / Q000662:veterinary; D065607:Cytochrome P-450 Enzyme Inhibitors; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D004917:Erythromycin / Q000494:pharmacology; D014453:Glucuronosyltransferase / Q000037:antagonists & inhibitors*; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology*; D009284:Naphthols / Q000494:pharmacology; D009675:Novobiocin / Q000494:pharmacology*; D013552:Swine / Q000378:metabolism*; D013739:Testosterone / Q000494:pharmacology
chemical_list: D065607:Cytochrome P-450 Enzyme Inhibitors; D004791:Enzyme Inhibitors; D009284:Naphthols; D009675:Novobiocin; C029350:1-naphthol; D000082:Acetaminophen; D013739:Testosterone; D004917:Erythromycin; D014453:Glucuronosyltransferase; C107611:UDP-glucuronosyltransferase, UGT1A7